Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Dec 14, 2019; 25(46): 6767-6780
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6767
Table 2 Association between fluorodeoxyglucose positron emission tomography/computed tomography detection of primary tumors and clinicopathological variables
VariablePositive (n = 29)Negative (n = 53)P value
Clinical variables
Sex0.88
Male2241
Female712
Age (yr), mean ± SD64.4 ± 11.364.8 ± 7.660.86
Tumor location
Upper thoracic24
Middle thoracic16300.98
Lower thoracic1119
Circumferential extension
< 3/421500.014
≥ 3/483
Macroscopic type
0-I32
0-IIa25500.46
0-IIc11
Pathological variables
Depth of tumor invasion
Tis + T1a1451< 0.001
T1b152
Length diameter of primary tumor (mm), mean ± SD36.4 ± 21.8727.2 ± 15.700.052
Infiltrative growth pattern
INFa941< 0.001
INFb2012
Histological grade
Well4260.002
Moderate+poor2527
Vascular invasion
Positive1140.001
Negative1849
Lymphatic invasion
Positive145< 0.001
Negative1548

  • Citation: Toriyama K, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Sasaki E, Abe T, Yatabe Y, Hara K, Matsuo K, Tamaki T, Niwa Y. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(46): 6767-6780
  • URL: https://www.wjgnet.com/1007-9327/full/v25/i46/6767.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v25.i46.6767